Gujarat Man’s Weight-Loss Pills Without Advice End in Cancer Diagnosis

A

recent case from Gujarat has raised serious concerns about the unsupervised use of weight-loss drugs. Ravi, a 55-year-old resident, began taking oral weight-loss pills after hearing about the benefits of Semaglutide - a medication originally designed for diabetes management but now widely used for obesity treatment. However, he ended up with medullary thyroid cancer.Also read: How Thalapathy Vijay Stays Fit at 50: His Diet and Workout Routine Revealed

The risk of self-medication

According to news reports, like many people seeking quick weight loss, Ravi avoided medical consultation and purchased pills over the counter. While injectable semaglutide is commonly prescribed under strict supervision, oral versions are increasingly accessible, leading to misuse. After several months, concerned about side effects, Ravi visited a specialist. During evaluation, he was diagnosed with Medullary thyroid cancer, a rare but serious form of thyroid cancer. Medullary thyroid cancer is a rare, often aggressive tumour that arises from parafollicular C cells, producing high levels of calcitonin. It is 75 per cent sporadic and 25 per cent inherited (linked to RET gene mutations/MEN2 syndrome). Primary treatment is total thyroidectomy, often with lymph node removal, as it does not respond to radioactive iodine.

The hidden risk factor

What made Ravi’s case particularly concerning was his family history of thyroid cancer - a key contraindication for GLP-1 drugs like semaglutide. Medical experts emphasize that individuals with such histories should never be prescribed these medications, as some animal studies have suggested a potential link between GLP-1 drugs and increased risk of this cancer type. According to experts, weight loss medications are not general solutions and must only be prescribed by qualified specialists such as diabetologists or internal medicine experts.

Understanding GLP-1 drugs

GLP-1 receptor agonists, including semaglutide, work by regulating blood sugar, slowing digestion, and reducing appetite, making them effective for both diabetes and weight management. However, their growing popularity has led to a surge in unsupervised usage, especially as cheaper versions enter the market. This trend raises a major public health concern. Without proper screening, patients may unknowingly expose themselves to serious risks, including hormonal imbalances, gastrointestinal issues, and, in rare cases, potential cancer-related concerns.

Why is medical supervision important?

Experts strongly warn against self-medication for weight loss. Before prescribing GLP-1 drugs, doctors typically evaluate a patient’s medical history, family history of cancers, existing health conditions, and hormonal and metabolic status. Skipping these steps can lead to dangerous consequences, as seen in Ravi’s case.

Safe weight loss: Here’s what you should do

Instead of relying on quick fixes, health professionals recommend a sustainable, medically guided approach:

• Follow a balanced diet rich in whole foods
• Incorporate regular physical activity
• Seek guidance from certified healthcare providers
• Avoid over-the-counter weight-loss medications without approval

Ravi’s experience highlights a growing issue: the misuse of modern weight-loss drugs in pursuit of fast results. While medications like semaglutide can be effective, they are not risk-free and require careful medical oversight. As experts warn, the rise of easily available weight-loss pills could lead to more such cases if awareness is not improved. The message is clear, when it comes to weight loss, safety must come before speed.